WIM
REGN icon

Westside Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Westside Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Sell
181
-1
-0.5% -$681 0.01% 409
2026
Q1 		$139K Buy
182
+100
+122% +$76.6K 0.02% 350
2025
Q4 		$63.4K Buy
82
+1
+1% +$679 0.01% 483
2025
Q3 		$46.7K Hold
81
– – 0.01% 562
2025
Q2 		$42.8K Buy
81
+31
+62% +$17.3K 0.01% 481
2025
Q1 		$31.7K Hold
50
– – 0.01% 476
2024
Q4 		$35.6K Hold
50
– – 0.01% 462
2024
Q3 		$52.6K Hold
50
– – 0.01% 397
2024
Q2 		$52.6K Hold
50
– – 0.01% 382
2024
Q1 		$48.1K Hold
50
– – 0.01% 385
2023
Q4 		$43.9K Hold
50
– – 0.01% 379
2023
Q3 		$41.1K Hold
50
– – 0.01% 373
2023
Q2 		$35.9K Hold
50
– – 0.01% 398
2023
Q1 		$41.1K Sell
50
-50
-50% -$37.7K 0.01% 381
2022
Q4 		$72 Hold
100
– – ﹤0.01% 388
2022
Q3 		$68 Hold
100
– – ﹤0.01% 388
2022
Q2 		$59 Hold
100
– – ﹤0.01% 395
2022
Q1 		$69 Hold
100
– – ﹤0.01% 393
2021
Q4 		$63 Hold
100
– – ﹤0.01% 385
2021
Q3 		$60 Hold
100
– – ﹤0.01% 379
2021
Q2 		$55 Hold
100
– – ﹤0.01% 372
2021
Q1 		$47 Buy
+100
New +$48.7K ﹤0.01% 379

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Westside Investment Management's REGN Position: Q2 2026 in Review

Westside Investment Management reduced its Regeneron Pharmaceuticals (REGN) stake by 0.55% in Q2 2026, selling an estimated $681 and leaving 181 shares worth $113K. The position accounts for 0.01% of the portfolio, ranked #409.

Westside Investment Management first reported a position in REGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $139K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Westside Investment Management held 181 shares of Regeneron Pharmaceuticals worth $113K as of Q2 2026.
  • Westside Investment Management sold 1 Regeneron Pharmaceuticals share in Q2 2026, an estimated $681.
  • Regeneron Pharmaceuticals made up 0.01% of Westside Investment Management's portfolio in Q2 2026, its #409 holding.
  • Westside Investment Management first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Westside Investment Management's Regeneron Pharmaceuticals position peaked at $139K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.